- 1.
Garrod A. Observations on the blood and urine of gout, rheumatism and Bright’s disease. Med Chir Trans 1848; 31: 83.
- 2.
Mohamed F. On chronic Bright’s disease, and its essential symptoms. Lancet 1879; 1: 399 – 401.
- 3.
Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2007; 14 (suppl 2): E1 – 40.
- 4.
Talbott JH, Terplan KL. The kidney in gout. Medicine (Baltimore) 1960; 39: 405 – 67.
- 5.
Breckenridge A. Hypertension and hyperuricaemia. Lancet 1966; 1: 15 – 8.
- 6.
Wu XW, Muzny DM, Lee CC et al. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992; 34: 78 – 84.
- 7.
Oda M, Satta Y, Takenaka O et al. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002; 19: 640 – 53.
- 8.
Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 2006; 73: 1059 – 64.
- 9.
Johnson RJ, Segal MS, Sautin Y et al. Potensial role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899 – 906.
- 10.
Vos MB, Kimmons JE, Gillespie C et al. Dietary fructose consumption among US children and adults: the third National Health and Nutrition Examination Survey. Medscape J Med 2008; 10: 160.
- 11.
van den Berghe G. Fructose: Metabolism and short-term effects on carbohydrate and purine metabolic pathways. Prog Biochem Pharmacol 1986; 21: 1 – 32.
- 12.
Cirillo P, Gersch MS, Mu W et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 2009; 20: 545 – 53.
- 13.
Stanhope KL, Schwarz JM, Keim NL et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119: 1322 – 34.
- 14.
Glushakova O, Kosugi T, Roncal C et al. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol 2008; 19: 1712 – 20.
- 15.
Nakagawa T, Hu H, Zharikov S et al. A causal role of uric acid in fructose-induced metabolic syndrom. Am J Physiol Renal Physiol 2006; 290: F625 – 31.
- 16.
Gersch MS, Mu W, Cirillo P et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 2007; 293: F1256 – 61.
- 17.
Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336: 309 – 12.
- 18.
Jalal DI, Smits G, Johnson RJ et al. Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 2010; 21: 1543 – 9.
- 19.
Perez-Pozo SE, Schold J, Nakagawa T el al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 2010; 34: 454 – 61.
- 20.
Erdogan D, Gullu H, Caliskan M et al. Relationship of uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005; 59: 1276 – 82.
- 21.
Zoccalli C, Maio R, Mallamaci F et al. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466 – 71.
- 22.
Feig DI, Johnson RJ. Hyperuricemi in childhood primary hypertension. Hypertension 2003; 42: 247 – 52.
- 23.
Feig DI, Nakagawa T, Karumanchi SA et al. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004; 66: 281 – 7.
- 24.
Franco MC, Christofalo DM, Sawaya AL et al. Effect of low birth weight in 8- to 13-year-old children. Implications in endothelial function and uric acid level. Hypertension 2006; 48: 45 – 50.
- 25.
Ford ES, Li C, Cook S et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526 – 32.
- 26.
Noman A, Ang DS, Ogston S et al. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010; 375: 2161 – 7.
- 27.
Obermayr RP, Temml C, Gutjahr G et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19: 2407 – 13.
- 28.
Weiner DE, Tighiouart H, Elsayed EF et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008; 19: 1204 – 11.
- 29.
Siu Y-P, Leung K-T, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower uric acid level. Am J Kidney Dis 2006; 47: 51 – 9.
- 30.
Livesy G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88: 1419 – 37.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.